11/19
11:53 am
aldx
ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap [Yahoo! Finance]
Medium
Report
ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap [Yahoo! Finance]
11/18
07:00 am
aldx
Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
Medium
Report
Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
11/14
07:00 am
aldx
Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference
Medium
Report
Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference
10/31
07:00 am
aldx
Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting
Low
Report
Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting
10/3
08:41 am
aldx
Aldeyra Therapeutics resubmits new drug application for treatment of dry eye disease [Seeking Alpha]
Medium
Report
Aldeyra Therapeutics resubmits new drug application for treatment of dry eye disease [Seeking Alpha]
10/3
07:00 am
aldx
Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
Low
Report
Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
9/5
07:00 am
aldx
Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
8/30
10:46 am
aldx
Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory [Yahoo! Finance]
Medium
Report
Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory [Yahoo! Finance]
8/28
05:11 pm
aldx
Aldeyra Therapeutics Has Data To Trigger AbbVie Partnership [Seeking Alpha]
Medium
Report
Aldeyra Therapeutics Has Data To Trigger AbbVie Partnership [Seeking Alpha]